MedPath

Rehabilitation After Breast Cancer

Not Applicable
Completed
Conditions
Breast Cancer
Interventions
Behavioral: Individually tailored nurse navigation
Registration Number
NCT03254875
Lead Sponsor
Danish Cancer Society
Brief Summary

The aim of the study is to evaluate whether a screening-based individually tailored nurse navigator intervention compared to standard care significantly reduce psychological and physical symptoms among women being treated for breast cancer who had moderate-to-severe distress (score ≥ 7 on the distress thermometer).

Detailed Description

During a 2-year period, 758 patients newly diagnosed with breast cancer will be screened for inclusion at the Section of Breast Surgery at Rigshospitalet, Copenhagen. Of these 324 participants enter the randomized controlled trial (RCT) and are randomized in a computer-generated sequence of 1:1 to the intervention (nurse-navigation) or control group (standard care). A total of 432 participants will enter an observational questionnaire study. All participants are followed for 1,5 years.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
309
Inclusion Criteria
  • Newly diagnosed with breast cancer (i.e. prior to surgery), scheduled for breast cancer surgery at Section of Breast Surgery at Rigshospitalet, 18 years or above, Danish citizen, read, understand and speak Danish, female gender,signed written informed consent. Those who experience high psychological distress (score ≥ 7 on the distress thermometer) will enter the RCT whereas those who experience low psychological distress (score < 7 on the distress thermometer) will be followed in an observational questionnaire study.
Exclusion Criteria
  • no severe cognitive problems or dementia, no severe psychiatric disease requiring treatment, e.g. schizophrenia, alcohol or narcotic dependence,

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
InterventionIndividually tailored nurse navigationIndividually tailored nurse navigation
Primary Outcome Measures
NameTimeMethod
DistressChange from baseline and to 6,12 months (mixed models)

Distress Thermometer

Secondary Outcome Measures
NameTimeMethod
Health related quality of life summary indexChange from baseline and to 18 months

The Trial Outcome Index-Physical/Functional/Breast (TOI-PFB) score including Domains:

* Physical well-being (PWB)

* Functional wellbeing (FWB)

* BC symptoms (BCS) from the Functional Assessment of Chronic Illness Therapy - Breast (FACT-B)

AnxietyChange from baseline and to 18 months

Generalized Anxiety Disorder (GAD7)

Neuropathy in the breast surgery area (side of chest, armpit or arm)Change from baseline and to 18 months

Self-developed scale

DistressChange from baseline to 18 months

Distress Thermometer

Breast cancer related quality of life summary indexChange from baseline and to 18 months

BC symptoms (BCS) from the Functional Assessment of Chronic Illness Therapy - Breast (FACT-B)

Functional related quality of life summary indexChange from baseline and to 18 months

Functional wellbeing (FWB) from the Functional Assessment of Chronic Illness Therapy - Breast (FACT-B)

Fear of recurrence18 months

Concerns About Recurrence Questionnaire (CARQ)

Pain in the breast surgery area (side of chest, armpit or arm)Change from baseline and to 18 months

Self-developed scale

Cognitive function - Perceived cognitive impairmentsChange from baseline and to 18 months

Functional Assessment of Chronic Illness Therapy - Cognitive function (FACT-cog) - Sub-scale Perceived cognitive impairments

DepressionChange from baseline and to 18 months

The Patient Health Questionnaire (PHQ9)

Physical health related quality of lifeChange from baseline and to 18 months

Physical well-being (PWB) from the Functional Assessment of Chronic Illness Therapy - Breast (FACT-B)

Social health related quality of lifeChange from baseline and to 18 months

Social/Family well-being (SWB) from the Functional Assessment of Chronic Illness Therapy - Breast (FACT-B)

Emotional health related quality of lifeChange from baseline and to 18 months

Emotional well-being (EWB) from the Functional Assessment of Chronic Illness Therapy - Breast (FACT-B)

Cognitive function- Perceived cognitive impairmentsChange from baseline and to 12 months

Functional Assessment of Chronic Illness Therapy - Cognitive function (FACT-cog) - Sub-scale Perceived cognitive impairments

Self-efficacyChange from baseline and to 18 months

Patient Activation Measure (PAM)

Sleep qualityChange from baseline and to 18 months

Pittsburgh Sleep Quality Index (PSQI)

Cognitive function - Perceived cognitive abilitiesChange from baseline and to 18 months

Functional Assessment of Chronic Illness Therapy - Cognitive function (FACT-cog) - Sub-scale - Perceived cognitive abilities

Cognitive function - Impact of Perceived cognitive impairments on quality of lifeChange from baseline and to 18 months

Functional Assessment of Chronic Illness Therapy - Cognitive function (FACT-cog) - Sub-scale - Impact of Perceived cognitive impairments on quality of life

Need for supportChange from baseline and to 18 months

Single self-developed items

Health care costsCumulative from baseline to 18 months

Costs will be obtained through registries on health care services and combined with information on health status using the 5Q-5D from the EuroQol Research Foundation's

Acceptability18 months

Single self-developed items

Trial Locations

Locations (1)

Rigshospitalet

🇩🇰

Copenhagen, Denmark

© Copyright 2025. All Rights Reserved by MedPath